| Serial Number | 87274467 |
| Word Mark | BIOHM |
| Filing Date | Tuesday, December 20, 2016 |
| Status | 702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED |
| Status Date | Thursday, January 2, 2025 |
| Registration Number | 5531063 |
| Registration Date | Tuesday, July 31, 2018 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, March 6, 2018 |
| Goods and Services | Probiotic supplements; vitamin and mineral supplements; vitamin supplements; whey protein supplements; dietary supplement drink mixes; dietary supplement for eliminating toxins from the intestinal tract; enzyme food supplements; herbal supplements; mineral supplements; multi-vitamin preparations; natural herbal supplements; nutraceuticals for use as a dietary supplement; nutritional supplement for eliminating toxins from the intestinal tract; nutritional supplement shakes; nutritional supplements, namely, probiotic compositions; nutritional supplements, namely, carbohydrates in powdered form; powdered nutritional supplement concentrate; vitamin and mineral supplements in powder, tablet, liquid, capsule or spray form; mineral supplements in powder, tablet, liquid, capsule or spray form; dietary supplements in powder, tablet, liquid, capsule or spray form; food supplements providing a source of vitamins and minerals and essential fatty acids and probiotic cultures in powder, tablet, liquid, capsule or spray form; nutritional supplements for human consumption providing a source of vitamins and minerals and essential fatty acids and probiotic cultures in powder, tablet, liquid, capsule or spray form; herbal supplements for general health and well-being, namely, in powder, tablet, liquid, capsule or spray form; nutritional supplements, namely, probiotic compositions in the nature of a vaginal probiotic for the treatment and prevention of bacterial and fungal vaginal infection; nutraceuticals for the treatment and prevention of bacterial vaginosis, vaginal discharge and odors, for preventing the growth of undesirable micro-organisms that can cause vaginal discharge and odor, killing bacteria that cause bacterial vaginosis, and for maintaining a desirable microflora in the vaginal cavity; micro-organisms culture for medical use, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and crohn's disease in which inflammation is present both in the small intestine and in the colon; pharmaceutical products containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and crohn's disease in which inflammation is present both in the small intestine and in the colon; pharmaceutical products, namely, probiotic lactic acid bacteria, probiotic bifidobacteria which are able to ferment and use the fibres in the human organism for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and crohn's disease in which inflammation is present both in the small intestine and in the colon, and dietary and nutritional supplements containing microorganisms and cultures of microorganisms, namely, probiotic lactic acid bacteria, probiotic bifidobacteria which are able to ferment and use the fibres in the human organism; pharmaceutical products for oral consumption, namely, capsules, tablets, solutions, suspensions, granules, and pellets in dried form, containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and crohn's disease in which inflammation is present both in the small intestine and in the colon, and dietary and nutritional supplements for oral consumption, namely, capsules, tablets, solutions, suspensions, granules, and pellets in dried form, containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacteria having probiotic activity on humans; microbial and biological preparations for medical use for improving the physical well-being of humans, namely, reducing inflammation and pain; dietary supplements for medical use, and baby food, all the above containing preparations and products resulting from the processing of microorganisms, particularly metabolites obtained from the processing of probiotic bacterial cultures; probiotic and nutritional and dietary supplements; antifungal preparations; antifungal creams for medical use; vaginal antifungal preparations; fungal and bacterial probiotic supplements, and nutritional supplement for digestive health; nutritional supplement for combating digestive disorders such as Crohn's Disease, ulcerative colitis and irritable bowel syndrome |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, September 25, 2017 |
| Primary Code | 005 |
| First Use Anywhere Date | Wednesday, March 1, 2017 |
| First Use In Commerce Date | Wednesday, March 1, 2017 |
| Party Name | BIOHM HEALTH INC. |
| Party Type | 32 - New Owner After Registration |
| Legal Entity Type | 99 - Other |
| Address | CLEVELAND, OH 44113 |
| Party Name | BIOHM HEALTH LLC |
| Party Type | 31 - New Owner After Registration |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Cleveland, OH 44115 |
| Party Name | PathoBiome LLC |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Cleveland, OH 44115 |
| Party Name | PathoBiome LLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Cleveland, OH 44115 |
| Party Name | PathoBiome LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Cleveland, OH 44115 |
| Event Date | Event Description |
| Wednesday, December 28, 2016 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, March 21, 2017 | ASSIGNED TO EXAMINER |
| Monday, March 27, 2017 | NON-FINAL ACTION WRITTEN |
| Monday, March 27, 2017 | NON-FINAL ACTION E-MAILED |
| Monday, March 27, 2017 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, June 20, 2017 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, June 20, 2017 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, June 21, 2017 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, July 17, 2017 | SUSPENSION LETTER WRITTEN |
| Monday, July 17, 2017 | LETTER OF SUSPENSION E-MAILED |
| Monday, July 17, 2017 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Tuesday, August 8, 2017 | PAPER RECEIVED |
| Monday, August 28, 2017 | ASSIGNED TO LIE |
| Wednesday, August 30, 2017 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, August 30, 2017 | AMENDMENT FROM APPLICANT ENTERED |
| Monday, September 25, 2017 | REMOVE FROM TEASRF |
| Monday, September 25, 2017 | NON-FINAL ACTION WRITTEN |
| Monday, September 25, 2017 | NON-FINAL ACTION E-MAILED |
| Monday, September 25, 2017 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, October 16, 2017 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, October 17, 2017 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, October 17, 2017 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Saturday, November 4, 2017 | SUSPENSION LETTER WRITTEN |
| Saturday, November 4, 2017 | LETTER OF SUSPENSION E-MAILED |
| Saturday, November 4, 2017 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Wednesday, January 31, 2018 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, February 14, 2018 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, March 6, 2018 | PUBLISHED FOR OPPOSITION |
| Tuesday, March 6, 2018 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, May 1, 2018 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Wednesday, May 9, 2018 | TEAS STATEMENT OF USE RECEIVED |
| Thursday, May 31, 2018 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Wednesday, May 9, 2018 | USE AMENDMENT FILED |
| Thursday, May 31, 2018 | STATEMENT OF USE PROCESSING COMPLETE |
| Monday, June 25, 2018 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Tuesday, June 26, 2018 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Tuesday, July 31, 2018 | REGISTERED-PRINCIPAL REGISTER |
| Wednesday, January 30, 2019 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Sunday, November 22, 2020 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Sunday, November 22, 2020 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Sunday, November 22, 2020 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Sunday, November 22, 2020 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Sunday, November 22, 2020 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Sunday, November 22, 2020 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Wednesday, February 15, 2023 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Monday, July 31, 2023 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Wednesday, July 31, 2024 | TEAS SECTION 8 & 15 RECEIVED |
| Tuesday, December 31, 2024 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Thursday, January 2, 2025 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
| Thursday, January 2, 2025 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |
| Tuesday, October 21, 2025 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Tuesday, October 21, 2025 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Tuesday, October 21, 2025 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |